SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-03-022630
Filing Date
2003-09-23
Accepted
2003-09-23 17:39:05
Documents
1
Period of Report
2003-09-15

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION boc79744-01em.html 4  
1 MAIN DOCUMENT DESCRIPTION boc79744-01em.xml 4 3598
  Complete submission text file 0001209191-03-022630.txt   5679
Mailing Address 28101 N. BALLARD DR. SUITE F LAKE FOREST IL 60045
Business Address 28101 N. BALLARD DR. SUITE F LAKE FOREST IL 60045 847-573-8990
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 509 MADISON AVE 14TH FL NEW YORK NY 10022
Business Address DISCOVERY LABORATORIES INC 509 MADISON AVE 14TH FLOOR NEW YORK NY 10022 2122234504
MYRIANTHOPOULOS EVAN (Reporting) CIK: 0001050955 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 03906682